| Wound Management |
1 |
0.77 |
| Biopsy |
0 |
0.53 |
| Pyoderma Gangrenosum |
0 |
0.46 |
| Dermatologic Surgery |
0 |
0.43 |
| Punch Biopsy |
0 |
0.43 |
| Vasculitis |
0 |
0.34 |
| Skin and Soft Tissue Infection |
0 |
0.32 |
| Inflammatory Bowel Disease |
0 |
0.31 |
| Aesthetic Medicine |
0 |
0.3 |
| Amputation |
0 |
0.3 |
| Crohn Disease |
0 |
0.23 |
| Smoking |
0 |
0.23 |
| Cosmetic Dermatology |
0 |
0.22 |
| Necrotizing Fasciitis |
0 |
0.21 |
| Osteomyelitis |
0 |
0.21 |
| Tobacco Cessation |
0 |
0.2 |
| White Blood Cell Count |
0 |
0.18 |
| Cardiac Surgery |
0 |
0.16 |
| Blood |
0 |
0.15 |
| Femoral |
0 |
0.15 |
| Patient History |
0 |
0.15 |
| Skin Lesion |
0 |
0.15 |
| Systemic Inflammatory Response Syndrome |
0 |
0.15 |
| Tissue |
0 |
0.15 |
| Bone Scan |
0 |
0.14 |
| Antibiotics |
0 |
0.13 |
| Clinical Guidelines |
0 |
0.13 |
| Intensive Care Unit (ICU) |
0 |
0.13 |
| Sepsis |
0 |
0.13 |
| Arrhythmia |
0 |
0.12 |
| Atrial Fibrillation |
0 |
0.12 |
| Care and Maintenance of Vision |
0 |
0.12 |
| Cerebrovascular Accident |
0 |
0.12 |
| Cataract |
0 |
0.11 |
| A-Scan Biometry |
0 |
0.08 |
| Bacteria |
0 |
0.08 |
| Bone |
0 |
0.08 |
| Calcineurin Inhibitor |
0 |
0.08 |
| Cellulitis |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| Cosmetics |
0 |
0.08 |
| Cyclosporine |
0 |
0.08 |
| Fever |
0 |
0.08 |
| Health Care Quality, Access, and Evaluation |
0 |
0.08 |
| Heart |
0 |
0.08 |
| Histology |
0 |
0.08 |
| Intravenous (IV) |
0 |
0.08 |
| Mitral Valve |
0 |
0.08 |
| Pacemaker |
0 |
0.08 |
| Pseudomonas Aeruginosa Infection |
0 |
0.08 |
| Remission |
0 |
0.08 |
| Scan |
0 |
0.08 |
| Staphylococcus Aureus Infection |
0 |
0.08 |
| Steroids |
0 |
0.08 |
| Surgery |
0 |
0.08 |
| Valve Replacement |
0 |
0.08 |
| Wound Healing |
0 |
0.08 |
| Xeroderma |
0 |
0.08 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Staphylococcal Infection |
0 |
0.07 |